Moran Wealth Management LLC increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,532 shares of the semiconductor company’s stock after acquiring an additional 62 shares during the quarter. Moran Wealth Management LLC’s holdings in Synopsys were worth $1,298,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of SNPS. Cornerstone Planning Group LLC lifted its position in shares of Synopsys by 275.0% in the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 44 shares in the last quarter. Saudi Central Bank bought a new stake in Synopsys in the first quarter worth $26,000. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 53 shares in the last quarter. Independence Bank of Kentucky raised its position in shares of Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 30 shares during the period. Finally, WPG Advisers LLC bought a new position in Synopsys in the 1st quarter worth $34,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Down 1.8%
Shares of SNPS stock opened at $435.90 on Thursday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $80.97 billion, a price-to-earnings ratio of 34.22, a P/E/G ratio of 4.89 and a beta of 1.10. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm has a fifty day moving average of $532.75 and a 200-day moving average of $510.07.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on SNPS shares. JPMorgan Chase & Co. cut their price target on Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. Piper Sandler dropped their price target on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Robert W. Baird reissued a “neutral” rating and set a $535.00 price objective (down from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. KeyCorp reduced their target price on Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Finally, Mizuho decreased their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a report on Thursday, September 11th. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $569.67.
View Our Latest Analysis on SNPS
Insiders Place Their Bets
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the sale, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer owned 20,520 shares of the company’s stock, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,894 shares of company stock worth $16,760,783. Company insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Are the U.K. Market Holidays? How to Invest and Trade
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.